the evaluation of the efficacy and safety of Fermented garlic on improving liver functio

Not Applicable

Recruiting

• Conditions: Diseases of the digestive system

• Registration Number: KCT0001181
• Lead Sponsor: Bioland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

1) older than 20 years and below 75 years
2) abnormal serum ?-GTP(gamma-glutamic transpeptidase) level and below 3-fold of normal range
3) individuals agreed to participate in the study voluntarily after sufficient explanation regarding the purpose and content of study

Exclusion Criteria

1) alcoholism or drug addiction, heart disease, central nerve system(CNS) disorder
2) liver schirosis or hepatoma on ultrasonography
3) Aspartate aminotransferase(AST) or alanine Aminotransferase(ALT) > 3-fold of normal range
4) Alkaline Phosphatase(ALP) or lactate dehydrogenase(LDH) > 3-fold of normal range or Platelet < 105/ml or AFP > 20 ng/mL
5) viral hepatitis
6) Hepatitis B surface antigen(HBs Ag) or antibodies to hepatitis C virus(HCV Ab) positive
7) Albumin = 3.5 g/dl or Total Bilirubin = 3 mg/dl

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
serum ?-GTP level

Secondary Outcome Measures

Name	Time	Method
AST and ALT;AST/ALT ratio;Multidimentional Fatigue Scale (MFS) ;Total-cholesterol, Triglyceride, HDL-cholesterol,LDL-cholesterol